Hypofractionated Radiotherapy Followed by Chemo-immunotherapy Induction Therapy

NCT06914050 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer, Small Cell
Limited-stage Small Cell Lung Cancer (LS-SCLC)

Interventions

DRUG: Adebrelimab
DRUG: EC/EP
RADIATION: SBRT
RADIATION: Chest radiotherapy

Sponsor

Tianjin Medical University Cancer Institute and Hospital